Sanofi (SNY) News Today $47.03 -0.62 (-1.30%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$47.40 +0.37 (+0.78%) As of 09/12/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Integrity Alliance LLC. Invests $706,000 in Sanofi $SNY1 hour ago | marketbeat.comAscent Group LLC Takes $426,000 Position in Sanofi $SNY1 hour ago | marketbeat.comGoldman Sachs Group Inc. Lowers Stock Position in Sanofi $SNY2 hours ago | marketbeat.comSanofi (NASDAQ:SNY) Receives Average Rating of "Buy" from Analysts3 hours ago | marketbeat.comZimmer Partners LP Sells 126,700 Shares of Sanofi $SNYSeptember 11 at 6:48 AM | marketbeat.comPress Release: Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degenerationSeptember 11 at 2:32 AM | markets.businessinsider.comPress Release: Sanofi's SAR402663 earns fast track designation in the US for neovascular age-related macular degenerationSeptember 11 at 2:00 AM | globenewswire.comSanofi (NASDAQ:SNY) Short Interest Up 35.2% in AugustSeptember 10, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Upgraded to Overweight at Morgan StanleySeptember 10, 2025 | marketbeat.comMandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS®September 10, 2025 | prnewswire.comSanofi’s Tzield approved in China to delay type 1 diabetes progressionSeptember 10, 2025 | msn.comAmundi Sells 289,018 Shares of Sanofi $SNYSeptember 10, 2025 | marketbeat.comPress Release: Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetesSeptember 10, 2025 | globenewswire.comSanofi (SNY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9, 2025 | seekingalpha.comPositive Report for Sanofi (SNYNF) from Morgan StanleySeptember 9, 2025 | theglobeandmail.comSanofi (NASDAQ:SNY) Stock Rating Upgraded by Morgan StanleySeptember 9, 2025 | americanbankingnews.comSanofi upgraded to Overweight from Equal Weight at Morgan StanleySeptember 8, 2025 | msn.comSanofi upgraded at Morgan Stanley on potential of amlitelimab vs. DupixentSeptember 8, 2025 | msn.comMorgan Stanley Upgrades Sanofi - Depositary Receipt () (SNY)September 8, 2025 | msn.comSanofi $SNY Position Increased by Parkwood LLCSeptember 8, 2025 | marketbeat.comPolar Asset Management Partners Inc. Acquires 33,138 Shares of Sanofi $SNYSeptember 8, 2025 | marketbeat.comAlyeska Investment Group L.P. Trims Stock Holdings in Sanofi $SNYSeptember 8, 2025 | marketbeat.comCinctive Capital Management LP Cuts Position in Sanofi $SNYSeptember 7, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Raises Holdings in Sanofi $SNYSeptember 7, 2025 | marketbeat.comBaird Financial Group Inc. Grows Stake in Sanofi $SNYSeptember 6, 2025 | marketbeat.comSanofi (SNY) Loses 9% as New Drug Candidate Appears Weaker Than PredecessorSeptember 5, 2025 | insidermonkey.comSanofi (SNY) Loses 9% as New Drug Candidate Appears Weaker Than PredecessorSeptember 5, 2025 | uk.finance.yahoo.comRoyal Bank of Canada Increases Stake in Sanofi $SNYSeptember 5, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Has $17.56 Million Position in Sanofi $SNYSeptember 5, 2025 | marketbeat.comSanofi amlitelimab data ‘well short of investor expectations,’ says BofASeptember 4, 2025 | msn.comSanofi’s New Experimental Eczema Drug Meets Goals Of Late-stage Trial, But Wall Street Expected MoreSeptember 4, 2025 | msn.comSanofi Tumbles As New Eczema Drug Lags Dupixent's 'Compelling Bar'September 4, 2025 | msn.comSanofi Hit With Shock As Flagship Drug Successor Disappoints InvestorsSeptember 4, 2025 | benzinga.comDeutsche Bank Aktiengesellschaft Upgrades Sanofi (NASDAQ:SNY) to BuySeptember 4, 2025 | marketbeat.comSanofi shares sink over 9% on weak trial results for experimental inflammation drugSeptember 4, 2025 | reuters.comSanofi's Eczema Drug Candidate Hits Main Goals in Late-Stage TrialSeptember 4, 2025 | wsj.comPress Release: Sanofi's amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitisSeptember 4, 2025 | globenewswire.comGlobal drugmakers rush to boost US presence as tariff threat loomsSeptember 3, 2025 | reuters.com1248 Management LLC Buys Shares of 7,054 Sanofi $SNYSeptember 3, 2025 | marketbeat.comSanofi $SNY Stake Trimmed by Hsbc Holdings PLCSeptember 3, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Upgraded to "Buy" at Deutsche Bank AktiengesellschaftSeptember 3, 2025 | americanbankingnews.comDeutsche Bank Upgrades Sanofi - Depositary Receipt () (SNY)September 3, 2025 | msn.comSanofi $SNY Shares Sold by Armistice Capital LLCSeptember 2, 2025 | marketbeat.comOLD Mission Capital LLC Invests $48.94 Million in Sanofi $SNYAugust 31, 2025 | marketbeat.comAmeriprise Financial Inc. Purchases 65,231 Shares of Sanofi $SNYAugust 30, 2025 | marketbeat.comSanofi: Sanofi's Wayrilz approved in US as first BTK inhibitor for immune thrombocytopeniaAugust 29, 2025 | finanznachrichten.deUS FDA approves Sanofi's drug for a rare blood disorderAugust 29, 2025 | reuters.comPress Release: Sanofi's Wayrilz approved in US as first BTK inhibitor for immune thrombocytopeniaAugust 29, 2025 | globenewswire.comSanofi $SNY Shares Purchased by Callodine Capital Management LPAugust 29, 2025 | marketbeat.comSanofi (SNY)’s Sarclisa Gets EMA Nod for Multiple MyelomaAugust 29, 2025 | finance.yahoo.com Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SNY Media Mentions By Week SNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNY News Sentiment▼0.930.92▲Average Medical News Sentiment SNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNY Articles This Week▼2324▲SNY Articles Average Week Get the Latest News and Ratings for SNY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Sanofi and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies NVS News AZN News NVO News GSK News TAK News ARGX News ONC News INSM News BNTX News TEVA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNY) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNY Stock Alerts